Results 11 to 20 of about 280,543 (339)

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

open access: yes, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo   +16 more
core   +8 more sources

The impact of dioctyl phthalate exposure on multiple organ systems and gut microbiota in mice

open access: yesHeliyon, 2023
Dioctyl phthalate, commonly known as bis(2-ethylhexyl) phthalate (DEHP), is a widely used plasticizer in various industries and has been shown to directly or indirectly impact human health. However, there is a lack of comprehensive studies evaluating the
Qiang Zhang   +7 more
doaj   +1 more source

Clinical implications of lncRNA LINC-PINT in cancer

open access: yesFrontiers in Molecular Biosciences, 2023
Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade.
Ihtisham Bukhari   +6 more
doaj   +1 more source

A study on the diagnosis of the Helicobacter pylori coccoid form with artificial intelligence technology

open access: yesFrontiers in Microbiology, 2022
BackgroundHelicobacter pylori (H. pylori) is an important pathogenic microorganism that causes gastric cancer, peptic ulcers and dyspepsia, and infects more than half of the world’s population. Eradicating H. pylori is the most effective means to prevent
Zishao Zhong   +17 more
doaj   +1 more source

A novel taxon selection method, aimed at minimizing recombination, clarifies the discovery of a new sub‐population of Helicobacter pylori from Australia

open access: yesEvolutionary Applications, 2020
We present a novel method for taxon selection, the aim being to minimize problems arising from highly recombinant species such as Helicobacter pylori.
Binit Lamichhane   +4 more
doaj   +1 more source

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice

open access: yesFrontiers in Nutrition, 2023
Background/aimsSome studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut microbiota may alter bile acid (BAs) composition and kinetics, improving non-alcoholic fatty liver disease (NAFLD ...
Minghua Yang   +14 more
doaj   +1 more source

Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. [PDF]

open access: yes, 2014
Understanding the transition of bacterial species from commensal to pathogen, or vice versa, is a key application of evolutionary theory to preventative medicine.
Koskella, Britt, Lin, Derek
core   +1 more source

Multiple pathways of plasmid DNA transfer in Helicobacter pylori [PDF]

open access: yes, 2012
Many Helicobacter pylori (Hp) strains carry cryptic plasmids of different size and gene content, the function of which is not well understood. A subgroup of these plasmids (e.g.
Benghezal, Mohammed   +5 more
core   +3 more sources

Prevalence of Helicobacter Pylori Infection and Associated Risk Factors among Chinese Children: a Meta-analysis [PDF]

open access: yesZhongguo quanke yixue, 2022
Background Helicobacter pylori is difficult to remove naturally in children after being infected with it. Due to differences in sample size and features, design and setting, there is little consistency between studies on epidemiology of Helicobacter ...
Wenhong LI, Ziwei LI, Na WANG, Jiaxiang YIN
doaj   +1 more source

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]

open access: yes, 1998
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Bayerdörffer, Ekkehard   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy